This website is intended for healthcare professionals only

touchNEUROLOGY

Search

Trending Topic

Developed by Touch

European Stroke Organisation Conference 2026: Expanding the boundaries of acute stroke care

Federica Rizzo, Ettore Nicolini, Antonio Ciacciarelli

The 12th European Stroke Organisation Conference (Maastricht, May 6–8, 2026) was dominated by studies testing the limits of acute stroke therapy, from thrombectomy and neuroprotection to secondary prevention. Supplementary Table 1 provides a comprehensive overview of the major studies presented during the conference. The large-core indication for thrombectomy is recent, and the ATLAS (Endovascular thrombectomy […]

touchREVIEWS in Neurology. 2026;22(1):Online ahead of journal publication

COVID-19

Amos Korczyn, CONy 2020 – Highlights from the President of CONy

Published Online: Dec 18th 2020

touchNEUROLOGY were delighted to have the opportunity to speak with Amos Korczyn, Founder and President of CONy about his highlights of this year’s virtual meeting.

Questions

What were your personal highlights of CONy 2020? (0:05)
Tell us about plans for CONy 2021 (4:43)

Support: Interview and filming supported by Touch Medical Media Ltd.

Disclosures: Founder and President of the Annual World Congress on Controversies in Neurology (CONy).

Filmed in coverage of the 14th World Congress on Controversies in Neurology (CONy Virtual, November 2020).

Trending Topic

Developed by Touch

Suman Kushwaha, MDS 2022: COVID-19 vaccine induced parkinsonism and cognitive dysfunction

Two cases of COVID-19 vaccination associated neurological symptoms were presented, with patients displaying parkinsonism and cognitive dysfunction. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behaviour and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms and investigations leading to the case report conclusions. The abstract entitled […]

Related Videos in COVID-19

Developed by Touch

Suman Kushwaha, MDS 2022: Neurological symptoms and COVID-19 vaccination

Neurological complications, such as peripheral neuropathy, have been associated with COVID-19 vaccination. In this touchNEUROLOGY interview, we speak with Dr Suman Kushwaha (Institute of Human Behavior and Allied Sciences (IHBAS), Dilshad Garden, Delhi, India) to discuss the neurological symptoms that ...

Developed by Touch

Raquel Gil-Gouveia, EAN 2022: Highlights in headache and migraine - Treatment advances, strategies for prevention, Anti-CGRP use in migraine, COVID-19

Headache is one of the most common nervous system disorders. In an interview with touchNEUROLOGY, Dr Raquel Gil-Gouveia (Hospital da Luz, Lisbon, Portugal) summarizes the ePoster session she chaired at EAN 2022, ranging from topics such as how COVID-19 has impacted ...

Developed by Touch

Davide Martino, AAN 2022: Functional neurological symptoms in the time of COVID-19 - Learning from tic-like behaviours

Functional neurological symptoms have been observed in young people globally during the COVID-19 pandemic, presenting with rapid onset of complex motor and vocal tic-like behaviours. Dr Davide Martino (Hotchkiss Brain Institute, University of Calgary, Calgary, Canada) discusses the rise in ...

Gabriel A de Erausquin, AAIC 2021: The Alzheimer's Association-led Global SARS-CoV-2 Consortium

touchNEUROLOGY joins Gabriel de Erausquin (UT Health San Antonio, TX, USA) at AAIC 2021 to discuss the Alzheimer's Association-led Global SARS-CoV-2 Consortium and the links between long-term cognitive dysfunction, acceleration of Alzheimer’s symptoms and COVID-19. Questions Could you tell us ...

Munro Cullum, AAIC 2021: Telehealth-based Assessment of Cognition in Older Adults

touchNEUROLOGY joins Prof Munro Cullum (UT Southwestern Medical Center, Dallas, TX, USA) at AAIC 2021 to discuss the challenges faced during the COVID-19 pandemic and the impact of telehealth on clinical practice. Questions 1. What challenges to dementia research have been posed ...

Robert Shapiro, AHS 2021: COVID-19 Incidence and Mortality Among Individuals with Migraine

touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine. The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency ...

Robert Shapiro, AHS 2021: Impact of COVID-19 on Patients with Migraine

touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine. The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency ...

Amy Gelfand, AHS 2021: COVID-19 Vaccines and Their Impact on Migraine Treatment

touchNEUROLOGY had the pleasure of meeting with Amy Gelfand (University of California, San Francisco, CA, USA) to discuss what is known about the impact of preventative migraine medication on the COVID-19 vaccine. The session ‘Vaccines and Their Impact on Migraine ...

Hannu Alho – Potential of Ondansetron in Alcohol Use Disorder (Part 2)

Professor Emeritus of Addiction Medicine, Hannu Alho (University of Helsinki, Finland) discusses the need for effective treatment options to manage alcohol use disorder, focusing on odansetron as a newly emerging possibility. Ondansetron is a specific 5HT3-receptor antagonist, which blocks 5...

Bengt Winblad, EAN 2020 – Swedish Geriatric Neurologist Perspective on COVID-19

Always a pleasure to catch-up with Editorial Board member, Bengt Winblad (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden), who chatted with us on several topics including his perspective on the COVID-19 pandemic as a Swedish geriatric neurologist. Question What ...

Andrew Chan, EAN 2020 – COVID-19 and Multiple Sclerosis

Great to catch-up with Andrew Chan (Inselspital Bern, University Hospital, University of Bern, Bern, Switzerland), who discussed challenges posed to patient care by COVID-19, factors to consider around immunosuppression for patients with multiple sclerosis (MS) during the pandemic, as well ...

Angelo Antonini, May 2020 - Neurological and Psychiatric Events in Patients with COVID-19

We caught up with our Editorial Board member, Angelo Antonini (University of Padova, Veneto, Italy), to discuss the neurological and psychiatric events that have been observed in patients with COVID-19, what could be done to prepare for these and if ...

Latest articles videos and clinical updates - straight to your inbox

Sign Up

Login

Sign Up FREE

Log into your Touch Account

Keep track of your clinical interests and newsletter subscriptions.

Error:

Forgot Password?

Or log in with

By proceeding, you agree to our terms & conditions.

For information about how we
use your data, see our privacy policy.

Register now for FREE Access

Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.

Sign up with an Email

Sign up with Google

Sign up with Facebook

Sign up with LinkedIn

Sign up with Microsoft

Already have an Account?

Login

Sign up with an Email

Or use a Social Account.

Error:

By clicking sign up you agree to the website
terms & conditions and privacy policy.

Register now for FREE access

Already registered? Login below.

Register

Login